Sentence examples for medication secondary from inspiring English sources

The primary endpoint was the proportion of patients with RSE controlled after a first course of study medication; secondary endpoints included clinical outcomes measures.

These include: primary care consultations, treatments and investigations, medication, secondary care consultations, and inpatient care.

Exclusion criteria were smoking, blood pressure-lowering medication, secondary hypertension, unstable coronary artery disease, diabetes mellitus, malignant diseases, alcohol abuse, milk allergy and pregnancy.

All patients had been treated previously with topical corticosteroids without any improvement and also they had to stop the medication secondary to intraocular pressure elevation.

There was also a trend for greater use of IOP-lowering medication secondary to the retina treatment in the combination therapy group.

Thus, 8 phenotypes were scrutinized, of which 2 were ICD-9 codes, one was hemoglobin A1c, another diabetes medication, diagnoses codes, lab results, medications, secondary data (demographic, social, environment, census, etc).

The Pharmacist-conducted HMR to Address the Risk of Medication-related Events in Retirement Villages (PHARMER) trial aims to test the effectiveness of a new multi-component intervention delivered by a pharmacist to increase the uptake of HMR among retirement village residents (primary aim), and to improve residents' adherence to medications (secondary aim).

In contrast, adherence was a function of patients' knowledge of disease and treatment, number of daily medications, achieving secondary education, and medication behaviour self-efficacy.

Meanwhile, as the medication for secondary stroke prevention, anti-platelet agents are commonly prescribed [7].

In this study, we investigated the features of recurrent stroke patients during EPA medication as secondary stroke prevention.

At Week 24, change from baseline in frequency of acute headache medication intakes (secondary endpoint) was not statistically significant (p = 0.210) between groups, except for triptan intakes (p < 0.001), where the onabotulinumtoxinA-treated group was favored.